多层次的见解:一种机器学习方法,用于对肝细胞癌的个性化预后评估
Zhao-Han Zhang1, Yunxiang Du2, Shuzhen Wei2
1Shenyang No.20 High School, Shenyang, China.
Frontiers in oncology
|March 15, 2024
概括
这项研究开发了肝细胞癌 (HCC) 的多层次预后风险模型,以改善患者的治疗结果. 在HCC多层次预后模型 (HCC-MLPM) 准确预测生存率和对治疗的反应.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 肝细胞癌 (HCC) 对准确的预后提出了复杂的挑战.
- 精确的预后评估对于定制HCC患者个性化治疗策略至关重要.
研究的目的:
- 开发一种新的HCC多层预后风险模型.
- 为HCC患者提供个性化的预后评估和治疗指导.
主要方法:
- 利用癌症基因组图集 (TCGA) 和SEER数据库进行差异基因表达分析.
- 开发了使用考克斯回归的HCC差异基因预测模型 (HCC-DGPM) 和HCC多级预测模型 (HCC-MLPM).
- 评估免疫功能,细胞透,免疫治疗反应 (IPS) 和临床药物反应.
主要成果:
- 使用七个差异表达基因构建了HCC-DGPM.
- 与未经调整的模型 (AUC=0.724) 相比,调整后的HCC-MLPM显示出更高的区分能力 (AUC=0.819).
- 外部验证证实了HCC-MLPM性能 (AUC=0.776) 以及其对免疫疗法和药物疗效的预测能力 (P <0.05).
结论:
- 开发的HCC-MLPM为HCC预后提供了全面的见解.
- 该模型增强了患者结果预测和治疗指导.
- 评估免疫和药物反应可以改善HCC管理策略.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.2K
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.3K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
